Clinical Trials Directory

Trials / Completed

CompletedNCT02546401

Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump

Comparison of Injection of an Analogue Bolus of Insulin Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
22 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The current study focuses on terms of use of Insulin Aspart, fast analogue of human insulin and commonly used in the treatment of type 1 diabetes, where it obtained the marketing authorization for this indication. In the patient who have an insulin pump, insulin Aspart is given daily like a pre-prandial bolus (just before the meal). However, many patients perform their bolus after the meal. However this insulin administration modality is not clearly studied in the literature.

Detailed description

The functional insulin therapy is a method for adjusting insulin doses which tends to mimic the physiology, especially when food intake with proportional dose calculation to the amount of carbohydrates ingested by the use of ratios. This method of adaptation, increasingly used in France, is an extension in the use of subcutaneous insulin pump with a more precise determination of bolus doses with meals, and use of aids dose calculations (assistant wizard for instance). In practice every day, some patients perform their bolus immediately after eating, not just before, allowing them to know exactly the amount of ingested carbohydrates and not the one provided in advance. This study is very interesting because it allows to compare the injection of an analogous bolus of fast insulin before and after the meal.

Conditions

Interventions

TypeNameDescription
DRUGInsulin AspartInjection of Insulin Aspart before or after meals

Timeline

Start date
2015-09-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-09-10
Last updated
2025-12-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02546401. Inclusion in this directory is not an endorsement.